Moderna Total Non-Operating Income/Expense 2017-2024 | MRNA
Moderna total non-operating income/expense for the twelve months ending December 31, 2024 was $338M, a 13.8% increase year-over-year.
- Moderna annual total non-operating income/expense for 2024 was $0.338B, a 13.8% increase from 2023.
- Moderna annual total non-operating income/expense for 2023 was $0.297B, a 91.61% increase from 2022.
- Moderna annual total non-operating income/expense for 2022 was $0.155B, a 1509.09% decline from 2021.